期刊文献+

母细胞性浆细胞样树突细胞肿瘤临床病理分析 被引量:1

Clinicopathological analysis of blast plasmacytoid dendritic cell neoplasm
下载PDF
导出
摘要 目的探讨母细胞性浆细胞样树突细胞肿瘤的临床病理学特征。方法应用光镜及免疫组化法观察母细胞性浆细胞样树突细胞肿瘤的组织学特点及免疫表型,并复习相关文献。结果母细胞性浆细胞样树突细胞肿瘤好发于老年患者,多以皮肤病变为首发症状,形态学表现为肿瘤细胞呈弥漫、密集、单一性浸润真皮及皮下组织,细胞中等大小,细胞浆量少,核卵圆形或不规则,染色质细,核分裂易见。免疫组化肿瘤细胞阳性表达CD4、CD56、CD123;而CD2、CD3、CD5、CD8、GranB、TIA-1、CD20、CD79a、PAX-5、MPO阴性。结论 BPDCN是一种罕见的淋巴造血系统恶性肿瘤,临床侵袭性强,易复发,预后差,应注意与其他淋巴造血系统肿瘤相鉴别。 Objective To investigate the clinicopathological characteristics of blast plasmacytoid dendritic cell neo- plasm. Methods The histological features and immunophenotype of blast plasmacytoid dendritic cell neoplasm were ob- served by light microscopy and immunohistochemistry. The related literature was reviewed. Results Blast plasmacytoid dendritic cell neoplasm was usually seen in the elderly patients, mostly with the skin lesions as the first symptom. Morphological manifestations were diffuse and dense tumor cells, and single infiltration of dermis and subcutaneous tis- sues. Cells were medium size, with less cytoplasm. The nueleolus was oval or irregular, the chromatin was fine, and the nuclear fission was easy to be observed. Immunohistochemistry showed that the tumor cells positively expressed CD4, CD56, CD123; CD2, CD3, CDS, CD8, GranB, TIA-1, CD20, CD79a, PAX-5, MPO were negative. Conclusion BPDCN is a rare lymphoid hematopoietie malignancy. The clinical invasiveness is high, and it is easy to relapse, with poor prognosis, which should be differentiated with other lymphoid hematopoietic tumors.
作者 顾昕 戴珍珍 丛玲华 陈鲧 方来福 GU Xin DAI Zhenzhen CONG Linghua CHEN Gun FANG Laifu(Department of Pathology, Yinzhou People's Hospital of Ningbo City, Ningbo 315040, China)
出处 《中国现代医生》 2017年第8期128-131,F0003,共5页 China Modern Doctor
基金 浙江省宁波市科技计划项目(2015C50015)
关键词 母细胞性浆细胞样树突细胞肿瘤 临床病理 免疫组化 预后 Blast plasmacytoid dendritic cell neoplasm Clinical pathology Immunohistochemistry Prognosis
  • 相关文献

参考文献1

二级参考文献8

  • 1Bekkenk MW, Jansen PM, Meijer CJ, et al. CD56^+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature[J]. Ann Oncol, 2004, 15(7): 1097-1108.
  • 2Li Y, Li Z, Lin HL, et al. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature[J]. Pathol Res Pract, 2011, 207 (1): 55-59.
  • 3Niakosari F, Sur M. Agranular CD4^+/CD56^+ hematodermic neoplasm: a distinct entity described in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas [J]. Arch Pathol Lab Med, 2007, 131(1): 149-151.
  • 4Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma[J]. Am J Hematol, 1994, 47(4): 278-282.
  • 5Petrella T, Facchetti F. Tumoral aspects of plasmacytoid dendritic ceils: what do we know in 2009? [J]. Autoimmunity, 2010, 43 (3): 210-214.
  • 6Pina-Oviedo S, Herrera-Medina H, Coronado H, et al. CD4^+/CD56^+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha)[J]. Appl Immunohistochem Mol Morohol, 2007, 15(4): 481-486.
  • 7Hwang K, Park CJ, Jang S, et al. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm [J]. HistoDathology. 2013. 62(5): 764-770.
  • 8薛汝增,陈永锋.母细胞性浆细胞样树突细胞肿瘤[J].国际皮肤性病学杂志,2010,36(6):351-353. 被引量:4

共引文献2

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部